Evaluation of Safety Profiles of Blood Cancer Drugs Approved in Japan

被引：0
|
作者：
Sachie Kubota
Kazuyuki Saito
Shunsuke Ono
Yasuo Kodama
机构：
[1] Josai International University,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
[2] National Center for Child Health and Development,Department of Development Strategy
[3] The University of Tokyo,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2016年 / 50卷
关键词：
safety profile; anticancer drug; NOAEL; clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：228 / 235
页数：7
相关论文
共 50 条
  • [41] Characteristics of drugs approved in Japan without conducting confirmatory clinical trials
    Izuka, Shunsuke
    Matsumaru, Naoki
    Tsukamoto, Katsura
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1582 - 1590
  • [42] Anticancer drugs use evaluation:: limits of the approved labeling
    Debrix, I
    André, T
    Flahault, A
    Kalu, O
    Gligorov, J
    Lotz, JP
    Milleron, B
    Pene, F
    Boukari, Y
    Becker, A
    [J]. BULLETIN DU CANCER, 2004, 91 (05) : 437 - 443
  • [43] Radiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors
    Rabe, Leonie
    Wenz, Frederik
    Ehmann, Michael
    Lohr, Frank
    Hofheinz, Ralf Dieter
    Buergy, Daniel
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 168 : 69 - 74
  • [44] Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer.
    Kadono, Toru
    Iwasa, Satoru
    Hirano, Hidekazu
    Shoji, Hirokazu
    Okita, Natsuko Okita
    Takashima, Atsuo
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 322 - 322
  • [45] New guidelines for clinical evaluation of anti-cancer drugs in Japan
    Minami, Hironobu
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S430 - S430
  • [46] Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan
    Tamaki, Chihiro
    Nagayama, Takashi
    Hashiba, Masamichi
    Fujiyoshi, Masato
    Hizue, Masanori
    Kodaira, Hiroshi
    Nishida, Minoru
    Suzuki, Kazuhiko
    Takashima, Yoshiharu
    Ogino, Yamato
    Yasugi, Daisaku
    Yoneta, Yasuo
    Hisada, Shigeru
    Ohkura, Takako
    Nakamura, Kazuichi
    [J]. JOURNAL OF TOXICOLOGICAL SCIENCES, 2013, 38 (04): : 581 - 598
  • [47] The Coverage in England of US-Approved Cancer Drugs
    Hashimoto, Takanao
    Ozaki, Akihiko
    Tanimoto, Tetsuya
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (09) : 1263 - 1263
  • [48] Vaccination ethics and Repurposing approved drugs for cancer therapy
    Vetter, Norman
    [J]. BRITISH MEDICAL BULLETIN, 2021, 137 (01)
  • [49] More cancer patients in England are getting approved drugs
    Mayor, Susan
    [J]. BRITISH MEDICAL JOURNAL, 2006, 333 (7570): : 671 - 671
  • [50] Contribution of mouse carcinogenicity study for safety assessment of pesticide approved in Japan
    Morita, Takeshi
    Toda, Moiu
    Inoue, Kaou
    [J]. TOXICOLOGY LETTERS, 2017, 280 : S232 - S232
12345